Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin.
Guglielmo
B J
BJ
Jacobs
R A
RA
D015377:Cilastatin / Q000009:adverse effects; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D016503:Drug Delivery Systems; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D006801:Humans; D015378:Imipenem / Q000009:adverse effects; D012307:Risk Factors; D012640:Seizures / Q000139:chemically induced* / Q000453:epidemiology
D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination